CLINICAL STUDIES
Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension
Eduardo Bossone, MD, PhDa,
Melvyn Rubenfire, MD, FACCa,
David S. Bach, MD, FACCa,
Mark Ricciardi, MDa and
William F. Armstrong, MD, FACCa
a Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
Manuscript received January 23, 1998;
revised manuscript received December 3, 1998,
accepted January 20, 1999.
Reprint requests and correspondence: Dr. William F. Armstrong, University of Michigan Hospital, Division of Cardiology, Women’s L3119, 1500 E. Medical Center Drive, Ann Arbor, Michigan 48109-0273
WFA{at}umich.edu
 |
Abstract
|
|---|
OBJECTIVES
The aim of this study was to explore the full range of tricuspid valve regurgitation velocity (TRV) at rest and with exercise in disease free individuals. Additionally we examined the relationship of stroke volume (SV), cardiac output (CO) and TRV to exercise capacity.
BACKGROUND
Doppler evaluation of TRV can be used to estimate pulmonary artery systolic pressure (PASP). Most studies have assumed TRV  2.5 m/s as the upper limits of normal. The full range of TRV with exercise has been incompletely defined.
METHODS
Highly conditioned athletes (n = 26) and healthy, active, young male volunteers (n = 14) underwent standardized recumbent bicycle exercise. Exercise parameters included: TRV, SV, CO, systolic (SBP) and diastolic (DBP) systemic blood pressure.
RESULTS
Tricuspid valve regurgitation, SV, HR and CO were significantly higher in athletes than in nonathletes over all workloads, including rest. Systolic blood pressure and DBP did not show significant differences between the two groups.
CONCLUSIONS
This study defines the upper physiologic limits of TRV at rest and during exercise in normals and provides a noninvasive standard for the diagnosis of pulmonary hypertension.
|
Abbreviations and Acronyms
| | CO | = cardiac output | | DBP | = diastolic blood pressure | | EF | = ejection fraction | | PASP | = pulmonary artery systolic pressure | | RAP | = right atrial pressure | | SBP | = systolic blood pressure | | SV | = stroke volume | | TRV | = tricuspid regurgitation velocity |
|
Tricuspid regurgitation peak velocity (TRV) has been shown to correlate with pulmonary artery systolic pressure (PASP) at rest (1–3) and with exercise (3–7). By using the modified Bernoulli equation ( p = 4V2), the pressure gradient between the right ventricle and right atrium can be calculated. Right ventricular systolic pressure can be calculated as: right ventricular systolic pressure = 4 TRV2 + right atrial pressure (RAP), where RAP equals estimated right atrial pressure. Right atrial pressure can be estimated from the jugular veins or from the inferior vena cava as imaged with two-dimensional echocardiography. Alternatively an empiric value can be utilized. There currently is no consensus among laboratories with respect to estimation of RAP for calculation of PASP. In the absence of obstruction to right ventricular outflow, right ventricular systolic pressure equals PASP. Traditionally it has been assumed that TRV 2.5 m/s. This corresponds to PASP 35 mm Hg (RAP assumed to be 10 mm Hg) and represents the upper limit in normals (1–3). The aim of this study was to explore the full spectrum of the physiologic TRV response during graded recumbent echo-Doppler bicycle exercise in young, highly conditioned male athletes and healthy, normal controls.
|
Methods
|
|---|
Study population.
We evaluated 26 NCAA Division I varsity male ice hockey players (mean age 20.26 ± 1.66 yr, range 18 to 23) with two-dimensional and Doppler echocardiography at rest and during recumbent bicycle exercise. For comparison we also evaluated 14 normally active (not competitive athletes) male volunteers (mean age 18.9 ± 0.9, range 18 to 21 years). Subject characteristics are outlined in Table 1. The study had been approved by the Human Subjects Review Committee at the University of Michigan.
2D echocardiography measurements.
Standard two-dimensional measurements (left ventricular diastolic and systolic diameters, interventricular septum and posterior wall thickness, left atrium, aorta, left ventricular outflow tract) were obtained in the parasternal long axis view with the patient in the left lateral position (8). Left ventricular ejection fraction (EF) was calculated by Simpson’s rule in the apical four chamber view (9). Left ventricular stroke volume was calculated as left ventricular outflow tract area x outflow tract time velocity integral. Cardiac output (CO) was calculated as SV x heart rate.
Echocardiography Doppler bicycle exercise.
The athletes and the control subjects underwent a standardized echocardiography Doppler bicycle exercise study in the recumbent position; workload was increased by 40 watts every 2 min to a maximum of 240 watts. The protocol included both a low intensity "warm up" and a "cool-down" phase. Variables of systolic performance and TRV were analyzed at each stage (10,11). Pulmonary artery systolic pressure was estimated at rest and during exercise as 4TRV2 + 5 mm Hg (12). Agitated saline was injected intravenously to enhance the continuous-wave spectral Doppler signal of tricuspid regurgitation in all subjects. All studies were reviewed and analyzed off line by two observers.
Statistical analysis.
Data for study population demographics and echocardiographic measurements (linear and volume) are presented as mean ± SD. Doppler data at the time of exercise are presented with 95% confidence intervals. Study population characteristics (age, weight, etc.) and left ventricular dimensions and volumes were compared based on Student t tests. For parameters measured during exercise (heart rate, blood pressure, Doppler parameters, PASP, etc.), athlete and nonathlete data were compared using repeated measures analysis of variance (SAS Proc Mixed software package, SAS Institute, Cary, North Carolina). An autoregressive covariance structure, which assumes a higher correlation for adjacent observations (i.e., sequential workloads), was employed in the analysis. For each variable of interest the effect for the athlete group was tested as well as the workload entered as a categorical variable. Because of the higher variance in the variable CO at higher workloads, a heterogeneous autoregressive covariance structure was used in the regression for CO. Interactions between workload and athlete group were tested but none was significant.
|
Results
|
|---|
Rest data.
Subject demographics are shown in Table 1. Nonathletes were significantly younger than the athletes by 1.4 years, although the ranges overlapped considerably (athletes, 18–23 yr; nonathletes, 18–21 yr). Athletes were significantly heavier than nonathletes by 7.5 kg, had greater body mass index (BMI) by 1.4 and significantly greater body surface area (BSA) by 0.1 m2. The two groups did not differ in height. Left ventricular end diastolic volume (LVEDV) was significantly higher and EF significantly lower in the athletes compared with normal healthy controls.
Exercise data.
Pulmonary artery systolic pressure (p = 0.0001; Fig. 1), TRV (p = 0.0001; Fig. 2A and Table 2), HR (p = 0.003; Fig. 2D), SV (p = 0.0003; Fig. 2E) and CO (p = 0.0267; Fig. 2F) showed significant differences between athletes and nonathletes over all workloads, including rest. There were no significant differences in systolic blood pressure (SBP) (p = 0.488; Fig. 2B) and diastolic blood pressure (DBP) (p = 0.469; Fig. 2C) between the two groups.
View larger version (21K):
[in this window]
[in a new window]
|
Figure 1 Calculated pulmonary artery systolic pressure response to exercise at each stage for athletes versus nonathletes. Mean value and 95% confidence intervals are given. Pulmonary artery systolic pressure was calculated using an assumed RA pressure of 5 mm Hg. Pulmonary artery systolic pressure was higher in athletes than in normals at each stage (p < 0.0001). WP = warm-up period.
|
|
View larger version (34K):
[in this window]
[in a new window]
|
Figure 2 (Panel A–F). Mean value (with 95% confidence limits) for each measured parameter at each stage during exercise for athletes and nonathletes. WP = warm-up period.
|
|
In general, all measures except DBP increased with increasing workload; the rate of increase differed between the groups. Tricuspid regurgitation velocity and the derived variable PASP increased in both groups up to a workload of 160 watts after which the athlete group continued to increase while the nonathlete group decreased. Systolic blood pressure, HR and CO increased linearly with increasing workload in both groups. Stroke volume (SV) increased moderately with increasing workload in both groups.
|
Discussion
|
|---|
Mechanisms of pressure elevation.
Previous invasive studies have demonstrated mild increases in pulmonary pressure with exercise in the normal population and higher pressures in athletes (13,14). In our study we have confirmed this difference. The factors which result in an increase in PASP with exercise are not fully known. A partial explanation lies in the increase in SV with increasing stress levels seen in both groups. The greater SV in athletes compared with normals would be in line with the greater increase in PASP. There was no significant difference between the two groups in SBP, suggesting that the mechanisms which regulate systemic arterial pressure with exercise are different and less flow dependent.
A second mechanism of increasing PASP is an increase in left atrial pressure with exercise (15–19). Both animal and clinical studies have demonstrated that left atrial pressure may increase to  20 mm Hg with maximal physical exertion. The relative contribution of increased flow and increased left atrial pressure to the increased PASP remains unclear. While not directly assessed in this study, prior studies have found that pulmonary vascular resistance does not rise with exercise and may even decline (16,17). As such, the elevation in PASP is most likely not related to primary changes in the pulmonary vasculature but is secondary to increases in flow and passive resistance due to an increase in left atrial pressure.
Clinical implications.
This study delineates the full range of TRV and the derived variable PASP with exercise and, therefore, can serve as a reference standard for the diagnosis of rest or exercise induced pulmonary hypertension in symptomatic individuals. The range of TRV and PASP reported here is higher than generally recognized and in part is due to the levels of stress achieved. Well-conditioned athletes were capable of reaching PASP of 60 mm Hg with exercise. When evaluating patients it is crucial to integrate workload and cardiac output with the TRV and PASP response to determine if an increase in PASP is a pathologic phenomenon or within the range of normal physiologic responses.
Study limitations.
It is important to underline a few limitations of this study. We evaluated the TRV response to exercise in a highly selected cohort of subjects with respect to gender, age and type of sport, all of which have been shown to impact cardiopulmonary performance. First, several prior studies have shown that age represents a major determinant in the physiologic variations of PASP (20–22). With increasing age there is a decrease in the pulmonary blood flow, an increase in the mean pulmonary pressure and an increase in pulmonary resistance, presumed related to reduced compliance of the pulmonary bed. Second, it has been demonstrated that physiologic cardiovascular adaptations to exercise are also dependent upon the type and magnitude of training (23–27). Greater increases in PASP are seen in individuals who engage in competitive sports requiring intermittent, intensive aerobic exercise as is the case with the athletes evaluated in this study (14).
In this study we have used a noninvasive technique to measure intracardiac pressures which is widely available and easily employed. In this study we did not attempt to measure RAP. Our results are reported as TRV and as PASP, using an assumed RAP of 5 mm Hg. This value of assumed RAP is consistent with previously known measured normals. While TRV is a quantifiable value which predictably increases with exercise, RAP may decrease or remain stable with exercise. Use of a fixed value for RAP may result in a mild systematic overestimation of PASP at higher workloads. By using a constant of 5 mm Hg, the degree of overestimation will be clinically insignificant.
Conclusions.
Athletes have higher TRV compared with healthy control subjects both at rest and during exercise. Higher SV and CO are major contributors to this phenomenon. The range of TRV during stress is higher than previously recognized and in highly conditioned athletes may reach 60 mm Hg, a level traditionally considered pathologic.
|
Footnotes
|
|---|
This study was internally funded by the Division of Cardiology, University of Michigan Health Care System.
|
References
|
|---|
1. Hatle L, Angelsen BAJ, Tromsodal A. Noninvasive estimation of pulmonary artery systolic pressure. Br Heart J. 1981;45:157–165[Abstract/Free Full Text]
2. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657–662[Abstract/Free Full Text]
3. Himelman RB, Schiller NB. Exercise Doppler: functional evaluation of right heart hemodynamics. Echocardiography. 1992;9:225–233[Medline]
4. Himelman RB, Stulbarg M, Kircher B, et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline enhanced Doppler echocardiography in chronic pulmonary disease. Circulation Ellestad MH, ed. 1989;79:863–71.
5. Himelman RB, Stulbarg MS, Lee E. Noninvasive evaluation of pulmonary artery systolic pressure during dynamic exercise by saline enhanced Doppler echocardiography: serial studies during medical and surgical therapy in a patient with severe pulmonary hypertension. Am Heart J. 1990;119:685–688[CrossRef][Medline]
6. Kuecherer HF, Will M, da Silva KG. Contrast enhanced Doppler ultrasound for noninvasive assessment of pulmonary artery pressure during exercise in patients with chronic congestive heart failure. Am J Cardiol. 1996;78:229–232[Medline]
7. Bach DS. Stress echocardiography for evaluation of hemodynamics: valvular heart disease, prosthetic valve function, and pulmonary hypertension. Prog Cardiovas Dis. 1997;39:543–554[CrossRef][Medline]
8. Feigenbaum H. Echocardiography evaluation of cardiac chambers. Echocardiography. 5th ed. Philadelphia, PA: Lea & Febiger; 1994. p. 134–180
9. Schiller NB, Shah PM, Crawford M. Recommendation for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echo. 1989;5:358–367
10. Oh JK, Seward JB, Tajik AJ. Hemodynamic assessment. The Echo Manual. 1st ed. Rochester, Minnesota: Mayo Foundation; 1994. p. 51–66
11. Weber KT. What can we learn from exercise testing beyond the detection of myocardial ischemia? Clin Cardiol. 1997;20:684–696[Medline]
12. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik J. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery disease. J Am Coll Cardiol. 1987;9:549–554[Abstract]
13. Palevsky HI. Exercise and the pulmonary circulation. Leff A. Cardiopulmonary Exercise Testing. 1st ed. Orlando, Fl: Grune & Stratton; 1986. p. 89–106
14. Bevegard S, Holmagren A, Jonsson B. Circulatory studies in well trained athletes at rest and during heavy exercise, with special reference to stroke volume and the influence of body position. Acta Physiol Scand. 1963;57:26–50[Medline]
15. West JB. Left ventricular filling pressures during exercise. A cardiological blind spot? Chest. 1998;113:1695–1697[Free Full Text]
16. Wagner PD, Gale GE, Moon RE, et al. Pulmonary gas exchange in humans exercising at sea level and simulated altitude. J Appl Physiol. 1986;61:260–270[Abstract/Free Full Text]
17. Groves BM, Reeves JT, Sutton JR, et al. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol. 1987;63:521–530[Abstract/Free Full Text]
18. Ekelund LG, Holmgren A. Central hemodynamics during exercise. Circ Res. 1967;30:I33–I43
19. Younes M, Bshouty Z, Ali J. Longitudinal distribution of pulmonary vascular resistance with very high pulmonary blood flow. J Appl Physiol. 1987;62:344–358[Abstract/Free Full Text]
20. Ellestad MH. Cardiovascular and pulmonary responses to exercise. Ellestad MH. Stress Testing: Principles and Practice. 4th ed. Philadelphia, PA: F.A. Davis Company; 1996. p. 11–41
21. Rich S, Braunwald E, Grossman W. Pulmonary hypertension. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia, PA: W.B. Saunders; 1997. p. 780–806
22. Granath A, Jonsson B, Strandell T. Circulation in healthy old men studied by right heart catheterization at rest and during exercise in supine and sitting position. Acta Medica Scandinavica. 1964;176:425–446[Medline]
23. Granath A, Strandell T. Relationship between output, stroke volume and intracardiac pressures at rest and during exercise in supine position and some anthropometric data in healthy old men. Acta Medica Scandinavica. 1964;176:447–466[Medline]
24. Holmegren A, Jonsson B, Sjostrand T. Circulatory data in normal subjects at rest and during exercise in recumbent position, with special reference to the stroke volume at different work intensities. Acta Physiologica Scandinavica. 1960;49:343–363[Medline]
25. Spirito P, Pelliccia A, Proschan M, et al. Morphology of the "athlete’s heart" assessed by echocardiography in 947 elite athletes representing 27 sports. Am J Cardiol. 1994;74:802–806[CrossRef][Medline]
26. Pelliccia A, Maron BJ, Spataro A, Proshan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295–301[Abstract]
27. Hopkins SR, Schoene RB, Henderson WR, Spragg RG, Martin TR, West JB. Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med. 1997;155:1090–1094[Abstract]
This article has been cited by other articles:
|
|
|
|
 
H. Mahjoub, F. Levy, M. Cassol, P. Meimoun, M. Peltier, D. Rusinaru, and C. Tribouilloy
Effects of age on pulmonary artery systolic pressure at rest and during exercise in normal adults
Eur J Echocardiogr,
July 1, 2009;
10(5):
635 - 640.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Grunig, S. Weissmann, N. Ehlken, A. Fijalkowska, C. Fischer, T. Fourme, N. Galie, A. Ghofrani, R. E. Harrison, S. Huez, et al.
Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension: Results of a Multicenter European Analysis of Pulmonary Artery Pressure Response to Exercise and Hypoxia
Circulation,
April 7, 2009;
119(13):
1747 - 1757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. La Gerche, A. J. Taylor, and D. L. Prior
Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions.
J. Am. Coll. Cardiol. Img.,
March 1, 2009;
2(3):
350 - 363.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J-W Ha, D Choi, S Park, C-Y Shim, J-M Kim, S-H Moon, H-J Lee, E-Y Choi, and N Chung
Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction
Heart,
March 1, 2009;
95(6):
490 - 494.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Tolle, A. B. Waxman, T. L. Van Horn, P. P. Pappagianopoulos, and D. M. Systrom
Exercise-Induced Pulmonary Arterial Hypertension
Circulation,
November 18, 2008;
118(21):
2183 - 2189.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bossone, R. Citro, W. F. Armstrong, and M. Rubenfire
Latent Pulmonary Hypertension: Looking Beyond the Scene
Chest,
August 1, 2008;
134(2):
469 - 470.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A La Gerche, K A Connelly, D J Mooney, A I MacIsaac, and D L Prior
Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise
Heart,
July 1, 2008;
94(7):
860 - 866.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Magne, M. Senechal, P. Mathieu, J. G. Dumesnil, F. Dagenais, and P. Pibarot
Restrictive Annuloplasty for Ischemic Mitral Regurgitation May Induce Functional Mitral Stenosis
J. Am. Coll. Cardiol.,
April 29, 2008;
51(17):
1692 - 1701.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Kiencke, A. Bernheim, M. Maggiorini, M. Fischler, S. V. Aschkenasy, L. Dorschner, J. Debrunner, K. Bloch, H. Mairbaurl, and H. P. Brunner-La Rocca
Exercise-induced pulmonary artery hypertension a rare finding?
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
513 - 514.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Huez and R. Naeije
Exercise stress tests for detection and evaluation of pulmonary hypertension
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H17 - H21.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-L. Vachiery and A. Pavelescu
Exercise echocardiography in pulmonary hypertension
Eur. Heart J. Suppl.,
December 1, 2007;
9(suppl_H):
H48 - H53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Taveira-DaSilva, O. M. Hathaway, V. Sachdev, Y. Shizukuda, C. W. Birdsall, and J. Moss
Pulmonary Artery Pressure in Lymphangioleiomyomatosis: An Echocardiographic Study
Chest,
November 1, 2007;
132(5):
1573 - 1578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Jarvis, B. D. Levine, G. K. Prisk, B. E. Shykoff, A. R. Elliott, E. Rosow, C. G. Blomqvist, and J. A. Pawelczyk
Simultaneous determination of the accuracy and precision of closed-circuit cardiac output rebreathing techniques
J Appl Physiol,
September 1, 2007;
103(3):
867 - 874.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Tumminello, P. Lancellotti, M. Lempereur, V. D'Orio, and L. A. Pierard
Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure
Eur. Heart J.,
March 1, 2007;
28(5):
569 - 574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. McLean, I. Ting, S. J. Huang, and S. Wesley
The use of the right ventricular diameter and tricuspid annular tissue Doppler velocity parameter to predict the presence of pulmonary hypertension
Eur J Echocardiogr,
March 1, 2007;
8(2):
128 - 136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bossone, R. Citro, F. Blasi, and L. Allegra
Echocardiography in Pulmonary Arterial Hypertension: An Essential Tool
Chest,
February 1, 2007;
131(2):
339 - 341.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. V. McLaughlin and M. D. McGoon
Pulmonary Arterial Hypertension
Circulation,
September 26, 2006;
114(13):
1417 - 1431.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Collins
Reply to the letter to the editor
Eur J Echocardiogr,
August 1, 2006;
7(4):
263 - 263.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Alkotob, P. Soltani, M. A. Sheatt, M. C. Katsetos, N. Rothfield, W. D. Hager, R. J. Foley, and D. I. Silverman
Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma.
Chest,
July 1, 2006;
130(1):
176 - 181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Grunig, C. Dehnert, D. Mereles, R. Koehler, H. Olschewski, P. Bartsch, and B. Janssen
Enhanced Hypoxic Pulmonary Vasoconstriction in Families of Adults or Children With Idiopathic Pulmonary Arterial Hypertension
Chest,
December 1, 2005;
128(6_suppl):
630S - 633S.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Grunig, C. Dehnert, D. Mereles, R. Koehler, H. Olschewski, P. Bartsch, and B. Janssen
Enhanced Hypoxic Pulmonary Vasoconstriction in Families of Adults or Children With Idiopathic Pulmonary Arterial Hypertension
Chest,
December 1, 2005;
128(6_suppl):
630S - 633S.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Rubin and D. B. Badesch
Evaluation and Management of the Patient with Pulmonary Arterial Hypertension
Ann Intern Med,
August 16, 2005;
143(4):
282 - 292.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bossone, B. D. Bodini, A. Mazza, and L. Allegra
Pulmonary Arterial Hypertension: The Key Role of Echocardiography
Chest,
May 1, 2005;
127(5):
1836 - 1843.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. McGoon, D. Gutterman, V. Steen, R. Barst, D. C. McCrory, T. A. Fortin, and J. E. Loyd
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines
Chest,
July 1, 2004;
126(1_suppl):
14S - 34S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Newman, R. C. Trembath, J. A. Morse, E. Grunig, J. E. Loyd, S. Adnot, F. Coccolo, C. Ventura, J. A. Phillips III, J. A. Knowles, et al.
Genetic basis of pulmonary arterial hypertension: Current understanding and future directions
J. Am. Coll. Cardiol.,
June 16, 2004;
43(12_Suppl_S):
33S - 39S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Barst, M. McGoon, A. Torbicki, O. Sitbon, M. J. Krowka, H. Olschewski, and S. Gaine
Diagnosis and differential assessment of pulmonary arterial hypertension
J. Am. Coll. Cardiol.,
June 16, 2004;
43(12_Suppl_S):
40S - 47S.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Galie, A. L. Hinderliter, A. Torbicki, T. Fourme, G. Simonneau, T. Pulido, N. Espinola-Zavaleta, G. Rocchi, A. Manes, R. Frantz, et al.
Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertension
J. Am. Coll. Cardiol.,
April 16, 2003;
41(8):
1380 - 1386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Finkelhor, S. X. Yang, G. Bosich, and R. C. Bahler
Unexplained Pulmonary Hypertension Is Associated With Systolic Arterial Hypertension in Patients Undergoing Routine Doppler Echocardiography
Chest,
March 1, 2003;
123(3):
711 - 715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Chemla, V. Castelain, P. Herve, Y. Lecarpentier, and S. Brimioulle
Haemodynamic evaluation of pulmonary hypertension
Eur. Respir. J.,
November 1, 2002;
20(5):
1314 - 1331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. M. McQuillan, M. H. Picard, M. Leavitt, and A. E. Weyman
Clinical Correlates and Reference Intervals for Pulmonary Artery Systolic Pressure Among Echocardiographically Normal Subjects
Circulation,
December 4, 2001;
104(23):
2797 - 2802.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. P. Blankfield, D. W. Hudgel, A. A. Tapolyai, and S. J. Zyzanski
Bilateral Leg Edema, Obesity, Pulmonary Hypertension, and Obstructive Sleep Apnea
Arch Intern Med,
August 14, 2000;
160(15):
2357 - 2362.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
Top
Abstract
Methods